|
PTBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.93640000000817E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.836500E-03 |
| Normal-vs-Stage2 |
2.217800E-01 |
| Normal-vs-Stage3 |
5.51359999999557E-05 |
| Normal-vs-Stage4 |
5.599000E-04 |
| Stage1-vs-Stage2 |
7.965600E-01 |
| Stage1-vs-Stage3 |
3.736000E-03 |
| Stage1-vs-Stage4 |
1.618160E-01 |
| Stage2-vs-Stage3 |
2.922100E-02 |
| Stage2-vs-Stage4 |
1.724180E-01 |
| Stage3-vs-Stage4 |
6.237400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.448900E-04 |
| Normal-vs-AfricanAmerican |
1.457260E-03 |
| Normal-vs-Asian |
3.020000E-02 |
| Caucasian-vs-AfricanAmerican |
5.951600E-01 |
| Caucasian-vs-Asian |
8.280600E-01 |
| AfricanAmerican-vs-Asian |
9.765400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.376400E-04 |
| Normal-vs-Female |
5.956200E-04 |
| Male-vs-Female |
4.257800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.398400E-03 |
| Normal-vs-Extreme_Weight |
5.977700E-03 |
| Normal-vs-Obese |
2.832900E-04 |
| Normal-vs-Extreme_Obese |
3.249200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.984600E-01 |
| Normal_Weight-vs-Obese |
5.106800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.796600E-01 |
| Extreme_Weight-vs-Obese |
2.459400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.484600E-01 |
| Obese-vs-Extreme_Obese |
3.720200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.35630000458664E-08 |
| Normal-vs-Age(41-60Yrs) |
1.77120000000031E-06 |
| Normal-vs-Age(61-80Yrs) |
2.098200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.827600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.666100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.229300E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.566430E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.877500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.924000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.841620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.14259999975886E-07 |
| Normal-VS-Type2 PRCC |
7.187000E-01 |
| Normal-VS-KIRP CIMP |
2.083700E-03 |
| Normal-VS-Unclassified PRCC |
4.826200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.64507999999008E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.219500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.749380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.838200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.807800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.890400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.402200E-02 |
| Normal-vs-N1 |
4.34609999999669E-06 |
| Normal-vs-N2 |
5.572400E-01 |
| N0-vs-N1 |
2.951100E-04 |
| N0-vs-N2 |
7.840600E-01 |
| N1-vs-N2 |
6.046500E-02 |
|
|
